CERA - Cera Sanitaryware Ltd. Share Price

Management provided a positive outlook for Cera Sanitaryware, projecting an overall revenue growth of 18% to 20% for FY27. This growth is expected to be driven primarily by a 12% increase in sanitaryware volumes, fueled by a projected 7% to 8% volume growth and a 5% to 6% price impact. For faucetware, the projected growth is 18%, attributed to a combination of a 10% to 12% volume increase and an 8% price impact.

In terms of operational initiatives, management emphasized that retail demand has shown signs of recovery, particularly with improvements noted in Q4 FY26, and they expect this trend to continue into FY27. They forecasted a stable balance in project and retail contributions, with expectations for 60% revenue from retail and 40% from projects.

Regarding pricing, the management implemented price increases of 12% in sanitaryware and 16% in faucetware over the past months to counter elevated brass costs, which have seen a year-on-year increase of approximately 30%. They anticipate that while input costs may remain volatile, improved demand conditions will allow for better management of trade discounts and margins.

For strategic growth, Cera plans to expand its brand architecture significantly. Senator is expected to generate revenues of around INR 40-45 crore in FY27, while Polipluz is projected to contribute INR 30-35 crore. Collectively, these brands are targeted to reach revenues of INR 70-80 crore in FY27.

Additionally, management highlighted plans for capacity expansion in faucetware to reach 5 lakh pieces per month, scheduled for operation by Q4 FY27, with a minimal capital expenditure of around INR 5 crore. They also expressed confidence in navigating supply disruptions due to geopolitical issues, ensuring operational continuity through effective inventory management and sourcing strategies.

Here are the major questions from the Q&A section of the earnings transcript, along with detailed answers:

Question 1: How do you see retail demand growing in FY27? What about the balance between institutional and retail contributions?

Answer: We saw retail demand recover from Q3 FY26, which has persisted into Q4. In April, this trend continues, and we anticipate retail demand to stabilize at about 60% growth for the year, with project contributions around 40%. Overall, we expect faucetware to grow 10-12% and sanitaryware 7-8% in volume.

Question 2: What challenges did you face in implementing price hikes, and how much more do you expect to take?

Answer: Brass prices surged from late 600s to about 800-850. We've implemented price hikes of 12% for sanitaryware and 16% for faucetware over the last two months. We anticipate minor adjustments to maintain margins, potentially where discounts can help offset about 1-2% gap.

Question 3: Can you give revenue figures for Senator and Polipluz, and what's the FY27 forecast?

Answer: In FY26, Senator generated about INR 10.5 crore and Polipluz around INR 8.5 crore, totaling approximately INR 19 crore. For FY27, we're targeting Senator at INR 40-45 crore and Polipluz at INR 30-35 crore, summing to around INR 70-80 crore.

Question 4: What is the overall revenue growth expectation for FY27?

Answer: We project total revenue growth of 18-20% for FY27, with sanitaryware growing 12% due to volume and price impacts, and faucetware growth at 18%, driven by 10-12% volume growth and a price impact of 8%.

Question 5: What's the status of employee costs and capex for FY27?

Answer: Q4 employee costs declined to around INR 59 crore due to revised liabilities, with expected growth in costs around 10%. We anticipate a total capex of INR 45 crore, which includes incremental capacity expansion and office space acquisition.

These answers encapsulate the core details and financial figures provided during the earnings call, adhering to the character limit specified.